• Clozapine N-oxide: Precision Chemogenetics for Neural Circui

  2026-04-30

  Clozapine N-oxide (CNO) enables highly selective, reversible control of neuronal circuits via DREADDs, making it an indispensable neuroscience research tool. This article details optimized experimental workflows, troubleshooting strategies, and unique insights from recent computational modeling, empowering researchers to maximize the specificity and reproducibility of CNO-driven chemogenetic assays.

• Drimartol B Suppresses AKT1-Glycolysis to Induce CRC Apoptos

  2026-04-30

  This study reveals that drimartol B, a sesquiterpene from Artemisia sphaerocephala, suppresses AKT1-mediated glycolysis to induce apoptosis in colorectal cancer (CRC) cells. By targeting the AKT1/GLUT1/HK2 pathway, drimartol B disrupts energy metabolism, highlighting a novel therapeutic mechanism with translational potential.

• ARCA EGFP mRNA (5-moUTP): Advanced Polyadenylated mRNA Tools

  2026-04-29

  ARCA EGFP mRNA (5-moUTP) redefines fluorescence-based transfection control with superior mRNA stability and minimized innate immune activation. This polyadenylated mRNA leverages advanced capping and nucleotide modifications, making it an ideal choice for reliable, reproducible protein expression in mammalian cells.

• Bovine Insulin as a Metabolic Switch: Mechanisms & Assay Imp

  2026-04-29

  Explore the emerging role of bovine insulin as a metabolic switch in cell culture, focusing on its mechanistic impact on insulin signaling and mitochondrial regulation. This in-depth analysis offers unique perspectives for advanced researchers.

• SB 202190 in Treg Modulation: A New Frontier in Cancer Immun

  2026-04-28

  Explore how SB 202190, a selective p38 MAP kinase inhibitor, advances inflammation research and cancer therapeutics by revealing new mechanisms in Treg cell modulation. This article uniquely bridges biochemical insights with translational immunology.

• Technical Guide: EdU Flow Cytometry Assay Kits (Cy5) Protoco

  2026-04-28

  The EdU Flow Cytometry Assay Kits (Cy5) address the need for reliable, denaturation-free detection of S-phase DNA synthesis, enabling accurate cell proliferation analysis by flow cytometry. This kit is best suited for applications requiring high sensitivity and compatibility with multiplex staining, but is not recommended when in situ imaging or fixed tissue analysis is required without protocol adaptation.

• Salinomycin: Molecular Ionophore Engineering for HCC Researc

  2026-04-27

  Dive deep into Salinomycin, a polyether ionophore antibiotic with advanced anti-cancer potential. This article uniquely dissects its molecular transport mechanisms and practical assay implications for hepatocellular carcinoma research.

• γH2AX DNA Damage Detection Kit: Decoding DNA Repair Kinetics

  2026-04-27

  Explore the γH2AX DNA Damage Detection Kit and its role as a DNA damage biomarker in quantifying DNA repair kinetics and evaluating genotoxicity. This article uniquely unpacks practical assay design, workflow optimization, and translational impacts for advanced DNA damage and repair research.

• MDM1 Overexpression Boosts p53-Mediated Apoptosis in CRC The

  2026-04-26

  This study reveals that MDM1 overexpression enhances p53 expression and apoptosis, increasing chemoradiotherapy sensitivity in colorectal cancer. The findings position MDM1 as a promising predictive biomarker and highlight actionable molecular pathways for overcoming therapy resistance.

• Applied ddATP: Precision in DNA Synthesis Termination Workfl

  2026-04-25

  ddATP (2',3'-dideoxyadenosine triphosphate) stands apart as a chain-terminating nucleotide analog, driving reliable DNA synthesis termination across Sanger sequencing, DNA repair, and viral replication research. This article translates recent breakthroughs and validated protocols into actionable guidance for workflow optimization and troubleshooting in both established and emerging molecular biology applications.

• Ampicillin Sodium in Antibacterial Assays: Protocols & Insig

  2026-04-24

  Ampicillin sodium, a benchmark β-lactam antibiotic, enables robust antibacterial activity assays and resistance modeling. This article delivers evidence-backed workflows, troubleshooting strategies, and comparative insights, guiding researchers to optimize experimental outcomes with APExBIO's high-purity reagent.

• Novobiocin Sodium: Precision Control of Bacterial Morphogene

  2026-04-24

  Explore how Novobiocin Sodium, an aminocoumarin antibiotic, uniquely enables precise modulation of bacterial cell morphology and DNA replication. Discover advanced assay design strategies grounded in novel mechanistic insights for metabolic enzyme and antibiotic resistance research.

• Liproxstatin-1: Precision Ferroptosis Inhibition in Advanced

  2026-04-23

  Liproxstatin-1 empowers researchers to dissect ferroptosis with nanomolar precision, offering robust inhibition of lipid peroxidation and unique selectivity against regulated cell death pathways. Explore how this APExBIO tool streamlines workflows, boosts reproducibility, and advances disease models from renal injury to cancer.

• Structure-Based Screening of Natural Product Inhibitors for

  2026-04-23

  This study pioneers a structure-based virtual screening approach to identify natural product inhibitors targeting NSP15, a key endoribonuclease in SARS-CoV-2. The identification and computational validation of thymopentin and oleuropein as potent NSP15 inhibitors highlight a novel antiviral strategy and offer a foundation for future translational research.

• GW4064: Non-Steroidal FXR Agonist for Advanced Metabolic Ass

  2026-04-22

  GW4064, a potent non-steroidal FXR agonist from APExBIO, enables precise FXR pathway interrogation in metabolic and fibrosis models. This guide delivers actionable workflows, recent mechanistic insights, and troubleshooting tips to optimize research on cholesterol, triglyceride, and bile acid metabolism.

454 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page